Anti-CD22 CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD22 CAR-T therapy, covering 2017-03-10 to 2017-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Anti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma Patients [Phase 1]